Clinical Trials Patient

Dr. Charles D. Fraser, Jr., Renowned Congenital Heart Surgeon, Named Surgeon ... - PR Newswire (press release)
( Wed, 10 Mar 2010 23:02:38 GMT+00:00 )

Dr. Charles D. Fraser, Jr., Renowned Congenital Heart Surgeon, Named Surgeon ...
PR Newswire (press release)
He currently serves as the National Principal Investigator in a first of its kind multi-center pediatric ventricular assist device trial to assess the ...

and more »

Response Genetics Announces Receipt of NASDAQ Non-Compliance Letter upon ... - istockAnalyst.com (press release)
( Wed, 10 Mar 2010 23:18:06 GMT+00:00 )

Response Genetics Announces Receipt of NASDAQ Non-Compliance Letter upon ...
istockAnalyst.com (press release)
... revenue from the sales of its proprietary analytical pharmacogenomic testing services of clinical trial specimens to the pharmaceutical industry. ...

and more »

Clark Johnson Appointed Neurologix President and CEO - Genetic Engineering News (press release)
( Wed, 10 Mar 2010 22:53:37 GMT+00:00 )

Clark Johnson Appointed Neurologix President and CEO
Genetic Engineering News (press release)
Neurologix recently announced completion of all planned surgeries in its Phase 2 clinical trial of the Company's gene transfer approach to the treatment of ...

and more »

Response Genetics Announces Receipt of NASDAQ Non-Compliance Letter upon ... - dBusinessNews San Jose (press release)
( Wed, 10 Mar 2010 22:36:09 GMT+00:00 )

Response Genetics Announces Receipt of NASDAQ Non-Compliance Letter upon ...
dBusinessNews San Jose (press release)
... revenue from the sales of its proprietary analytical pharmacogenomic testing services of clinical trial specimens to the pharmaceutical industry. ...

and more »

TRANSGENE SIGNS AN EXCLUSIVE OPTION AGREEMENT FOR THE DEVELOPMENT AND ... - PipelineReview.com (press release)
( Thu, 11 Mar 2010 00:10:11 GMT+00:00 )

TRANSGENE SIGNS AN EXCLUSIVE OPTION AGREEMENT FOR THE DEVELOPMENT AND ...
PipelineReview.com (press release)
Results from the phase IIb portion of this combined phase IIb/III clinical trial are expected to be available in the first quarter of 2012. ...

and more »

WBOC-TV 16, Delmarvas News Leader, FOX 21 - Affymax receives $5M payment for ... - WBOC TV 16
( Wed, 10 Mar 2010 22:36:57 GMT+00:00 )

WBOC-TV 16, Delmarvas News Leader, FOX 21 - Affymax receives $5M payment for ...
WBOC TV 16
The US Phase 3 clinical program enrolled about 2600 chronic renal failure patients at approximately 400 clinical trial sites.

and more »

GTC Biotherapeutics to Webcast Corporate Presentation at the ROTH 22nd Annual ... - dBusinessNews San Jose (press release)
( Wed, 10 Mar 2010 22:36:07 GMT+00:00 )

GTC Biotherapeutics to Webcast Corporate Presentation at the ROTH 22nd Annual ...
dBusinessNews San Jose (press release)
GTC aims to initiate a clinical trial in this indication in the second half of 2010. In addition to ATryn , GTC is developing a portfolio of recombinant ...

and more »

GTC Biotherapeutics to Webcast Corporate Presentation at the ROTH 22nd Annual ... - dBusinessNews Boston (press release)
( Wed, 10 Mar 2010 22:41:13 GMT+00:00 )

GTC Biotherapeutics to Webcast Corporate Presentation at the ROTH 22nd Annual ...
dBusinessNews Boston (press release)
GTC aims to initiate a clinical trial in this indication in the second half of 2010. In addition to ATryn , GTC is developing a portfolio of recombinant ...

and more »

Mitchell Posner named president of the Society of Surgical Oncology - Article Ant (press release)
( Wed, 10 Mar 2010 23:30:42 GMT+00:00 )

Mitchell Posner named president of the Society of Surgical Oncology
Article Ant (press release)
... to clinical trials research. With more than 2000 physician members, the SSO is dedicated to promoting the highestquality surgical oncology patient care ...

and more »

Mayo Clinic Receives Unique Philanthropic Gift for Cancer Research - PharmaLive.com (press release)
( Wed, 10 Mar 2010 22:41:48 GMT+00:00 )

Mayo Clinic Receives Unique Philanthropic Gift for Cancer Research
PharmaLive.com (press release)
... obtaining national funding and industry support for clinical trials in these arenas, and actively leading a nationally funded laboratory research ...

and more »

Sponsors Get FDA's Thinking on Adaptive Trial Protocols - FDA news (subscription)
( Wed, 10 Mar 2010 22:40:18 GMT+00:00 )

Sponsors Get FDA's Thinking on Adaptive Trial Protocols
FDA news (subscription)
The FDA has proposed the first draft guidance on adaptive design protocols for clinical trials, including details for standard operating procedures, ...

Patient safety reporting and drug label accuracy missing vital information - PhysOrg.com
( Wed, 10 Mar 2010 23:02:35 GMT+00:00 )

Patient safety reporting and drug label accuracy missing vital information
PhysOrg.com
Dr. Basch has found that clinicians - the current responsible party for collecting and reporting symptoms in clinical trials - systematically miss important ...

and more »

Glasgow Health Solutions Ltd: Conference Offers Hope for People with MS - PharmaLive.com (press release)
( Wed, 10 Mar 2010 22:27:33 GMT+00:00 )

Glasgow Health Solutions Ltd: Conference Offers Hope for People with MS
PharmaLive.com (press release)
She set up the charity LDN Research Trust with the aim of increasing awareness and to raise funds for clinical trials. The LDN Research Trust has a database ...

Response Genetics Announces Receipt of NASDAQ Non-Compliance Letter upon ... - FOXBusiness
( Wed, 10 Mar 2010 23:18:39 GMT+00:00 )

Response Genetics Announces Receipt of NASDAQ Non-Compliance Letter upon ...
FOXBusiness
... revenue from the sales of its proprietary analytical pharmacogenomic testing services of clinical trial specimens to the pharmaceutical industry. ...

and more »

Nabi Biopharmaceuticals logs revenue from Glaxo sale - MSN Money
( Wed, 10 Mar 2010 23:24:54 GMT+00:00 )

Nabi Biopharmaceuticals logs revenue from Glaxo sale
MSN Money
... to fund and conduct the vaccine's development. It expects to report results from two Phase III clinical trials with NicVax in the second half of 2011.

and more »

Response Genetics Announces Receipt of NASDAQ Non-Compliance Letter upon ... - dBusinessNews Sacramento (press release)
( Wed, 10 Mar 2010 22:32:12 GMT+00:00 )

Response Genetics Announces Receipt of NASDAQ Non-Compliance Letter upon ...
dBusinessNews Sacramento (press release)
... revenue from the sales of its proprietary analytical pharmacogenomic testing services of clinical trial specimens to the pharmaceutical industry. ...

and more »

Complete the Form Below
and Unlock Your
Mobile Phone instantly!

Name

Email

Mobile/Cell Phone

How did you find us

fgproperty.org		Home Contact Us